Clinical Trial Update: A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase I trial evaluating suramin for superficial transitional cell carcinoma of the bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• Suramin (suramin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Neoplasms, Carcinoma, Transitional Cell | Phase 1 | Status: COMPLETED